Opaleye Management Inc. Viracta Therapeutics, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.37 - $7.91 $871,333 - $2.05 Million	-258,556 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$7.84 - $12.53 $10,717 - $17,128	1,367 Added 0.53%	258,556 $2.07 Million
Q2 2021 Aug 16, 2021	BUY	$7.55 - $12.95 $1.16 Million - $1.99 Million	153,589 Added 148.25%	257,189 $2.92 Million
Q1 2021 May 18, 2021	BUY	$7.58 - $18.67 $785,288 - $1.93 Million	103,600 New	103,600 $958,000

9.04M

10.9K

400

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $8.26M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.